68Ga-PSMA-11 PET/CT has a high lesion detection rate for biochemical recurrence of prostate cancer at a serum PSA level of <10.0 ng/mL in patients previously treated with radical prostatectomy or external beam radiotherapy. This evidence concerns the gene FOLH1 and prostate cancer.